Pitch Summary:
commercialization is further away than bulls expect and economics won’t justify today’s valuation. Highlights operational constraints and regulatory/timing risks on “driver-out.” Warns cash burn implies future capital raises/dilution.
BSD Analysis:
Kerrisdale’s short case on Aurora stresses the gap between management’s ambitious timelines and the entrenched difficulties of Level 4 autonomy. Despite a decade of R&D, Aurora has yet ...
Pitch Summary:
The investment thesis for Acuren is based on the strategic merger with NV5, which is expected to unlock significant synergies and operational improvements. The merger aims to diversify revenue streams, reduce dependency on the oil and gas sector, and leverage complementary services for cross-selling opportunities.
BSD Analysis:
The merger between Acuren and NV5 is anticipated to yield $20 million in synergies, primarily through cr...
Pitch Summary:
The author highlights LSBK as an overlooked post-conversion thrift with early-stage special-situation dynamics. Following the completed second-step conversion, activist investor Stillwell accumulated a 10% stake and filed a 13D, signaling potential governance pressure and improved capital allocation ahead. Although the bank cannot be sold for three years, buybacks could begin within roughly 12 months, opening the door for tangible ...
Published: Aug 18, 2025
Description: Plus, whether it’s too late to invest in international stocks, who needs bonds, and what role dividend stocks should play in an … Transcript: [Music] Thank you. [Music] Hello, I’m Susan Chabinsky and welcome to a special episode of the Morning Filter podcast. Now, usually I sit down every Monday morning with Morning Star’s […]...
Published: Aug 18, 2025
Published: Aug 18, 2025
Published: Aug 18, 2025
Published: Aug 18, 2025
Published: Aug 18, 2025
Published: Aug 18, 2025
Published: Aug 18, 2025
Published: Aug 18, 2025
Bull
Pitch Summary:
FitLife Brands is a capital-light nutritional supplements company that has been transformed by CEO Dayton Judd, a disciplined investor and exceptional capital allocator who rescued the business from near-bankruptcy and turned it into a compounding platform. Under Judd’s leadership, FitLife has successfully executed a repeatable M&A strategy, acquiring distressed but high-quality brands and restoring profitability through cost contr...
Pitch Summary:
Opendoor’s iBuying house-flipping model has proven structurally unprofitable, with ~$3.8B cumulative losses and only one profitable quarter during peak HPA. Attempts to pivot to asset-light models (“Key Connections” lead-gen and “Cash Plus” hybrid flips) are weak, plagued by poor customer alignment and thin economics. CEO Wheeler’s abrupt resignation amid retail-driven activism (via Eric Jackson and Pompliano) suggests insider supp...
Pitch Summary:
Claims heavy dependence on Zio with reimbursement and competitive pressure makes the model fragile. Flags accounting/quality and disclosure issues that it believes overstate true performance. Concludes the premium valuation is unjustified vs. med-tech peers.
BSD Analysis:
Spruce Point’s thesis stresses iRhythm’s overdependence on Zio monitors and reimbursement uncertainty. Medicare policies and payer dynamics drive revenue concent...
Pitch Summary:
Calls the AI trade frothy and argues Palantir’s valuation embeds unrealistic AI optimism. Suggests a fair value near $40 with substantial downside from recent prices. Uses contemporaneous OpenAI valuation chatter to contextualize the perceived bubble.
BSD Analysis:
The Bear Cave frames Palantir as emblematic of the “AI bubble” — richly valued on promises of transformative software adoption but with limited evidence of broad enterp...
Pitch Summary:
Funko is reviewing strategic alternatives, including a possible sale, as it faces declining revenues and compressed margins. Despite current challenges, the company has a significant revenue base and potential for margin improvement.
BSD Analysis:
Funko's shares are trading at all-time lows, reflecting the market's concerns over its financial health and strategic direction. The company has a history of achieving over 10% EBITDA ma...
Published: Aug 17, 2025
Published: Aug 17, 2025
Published: Aug 16, 2025